CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
pneumonia (CAP) or moderate / severe Coronavirus Disease 2019 (COVID-19) pneumonia.Other objectives are to determine pharmacokineti...
Phase 3
Paris, France and 63 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Créteil, Ile-de-France, France and 66 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
Paris, Ile-de-France, France and 140 other locations
The COVID-19 pandemic is a novel medical challenge, particularly because of the systemic nature of this disease. Indeed, COVID...
Paris, France
NEUROCOVID is a prospective multicenter study comparing the proportion of patients with SARS-CoV-2 viral RNA at the level of the olfactory clefts in...
Paris, France and 1 other location
One of the current health challenges in the face of the COVID-19 pandemic that started in Wuhan in 2019, and still responsible for ...
Paris, France
Currently, there is no approved treatment for COVID-19 in France, either for the acute phase, nor for the late chronic phase. the i...
Phase 3
Paris, France
The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants...
Phase 2
Paris 15, France and 35 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...
Phase 3
Paris cedex 10, Paris, France and 246 other locations
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...
Phase 3
Créteil, France and 441 other locations
Clinical trials
Research sites
Resources
Legal